Literature DB >> 10389754

Presence of high levels of MT1-MMP protein in fibroblastic cells of human invasive carcinomas.

M P Chenard1, Y Lutz, A Mechine-Neuville, I Stoll, J P Bellocq, M C Rio, P Basset.   

Abstract

Matrix metalloproteinase 2 (MMP2) activity is associated with the aggressiveness of human cancers. Therefore, the mechanisms regulating its activation are of great interest for a better understanding of malignant invasive processes. MT1-MMP, a membrane-bound MMP, is involved in the conversion of the latent form of MMP2 to the active one. In the present study, we have raised 3 monoclonal antibodies (Mabs) directed against 3 different epitopes of human MT1-MMP, which we used to investigate the expression and cellular localization of MT1-MMP protein in human carcinomas. MT1-MMP protein was present in all invasive carcinomas tested, and it was almost exclusively located to the stromal cells and not to cancer cells as previously reported, suggesting that MMP2 activation might be a peri-fibroblastic event.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10389754     DOI: 10.1002/(sici)1097-0215(19990719)82:2<208::aid-ijc10>3.0.co;2-9

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  13 in total

1.  MT1-MMP hemopexin domain exchange with MT4-MMP blocks enzyme maturation and trafficking to the plasma membrane in MCF7 cells.

Authors:  Susan J Atkinson; Christian Roghi; Gillian Murphy
Journal:  Biochem J       Date:  2006-08-15       Impact factor: 3.857

2.  Regulation of membrane type-1 matrix metalloproteinase activation by proprotein convertases.

Authors:  I Yana; S J Weiss
Journal:  Mol Biol Cell       Date:  2000-07       Impact factor: 4.138

3.  The metalloproteinase inhibitor TIMP-2 is down-regulated by androgens in LNCaP prostate carcinoma cells.

Authors:  Ase Bratland; Erlend Ragnhildstveit; Kristin Bjørnland; Kristin Andersen; Gunhild Mari Maelandsmo; Oystein Fodstad; Fahri Saatcioglu; Anne Hansen Ree
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

4.  Expression of proteinases and inhibitors in human breast cancer progression and survival.

Authors:  E A Baker; T J Stephenson; M W R Reed; N J Brown
Journal:  Mol Pathol       Date:  2002-10

5.  Membrane type 1 matrix metalloproteinase-mediated stromal syndecan-1 shedding stimulates breast carcinoma cell proliferation.

Authors:  Gui Su; Stacy A Blaine; Dianhua Qiao; Andreas Friedl
Journal:  Cancer Res       Date:  2008-11-15       Impact factor: 12.701

Review 6.  Fibroblasts in the Tumor Microenvironment: Shield or Spear?

Authors:  Twana Alkasalias; Lidia Moyano-Galceran; Marie Arsenian-Henriksson; Kaisa Lehti
Journal:  Int J Mol Sci       Date:  2018-05-21       Impact factor: 5.923

7.  Wnt signaling activation and mammary gland hyperplasia in MMTV-LRP6 transgenic mice: implication for breast cancer tumorigenesis.

Authors:  J Zhang; Y Li; Q Liu; W Lu; G Bu
Journal:  Oncogene       Date:  2009-11-02       Impact factor: 9.867

8.  The interaction of IQGAP1 with the exocyst complex is required for tumor cell invasion downstream of Cdc42 and RhoA.

Authors:  Mika Sakurai-Yageta; Chiara Recchi; Gaëlle Le Dez; Jean-Baptiste Sibarita; Laurent Daviet; Jacques Camonis; Crislyn D'Souza-Schorey; Philippe Chavrier
Journal:  J Cell Biol       Date:  2008-06-09       Impact factor: 10.539

9.  Comprehensive profiling and localisation of the matrix metalloproteinases in urothelial carcinoma.

Authors:  M J Wallard; C J Pennington; A Veerakumarasivam; G Burtt; I G Mills; A Warren; H Y Leung; G Murphy; D R Edwards; D E Neal; J D Kelly
Journal:  Br J Cancer       Date:  2006-02-27       Impact factor: 7.640

10.  Functional relationship between matrix metalloproteinase-11 and matrix metalloproteinase-14.

Authors:  Emilie Buache; Robert Thai; Corinne Wendling; Fabien Alpy; Adeline Page; Marie-Pierre Chenard; Vincent Dive; Marc Ruff; Annick Dejaegere; Catherine Tomasetto; Marie-Christine Rio
Journal:  Cancer Med       Date:  2014-08-01       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.